Company: BLNE
Filing Date: 2025-10-08
Form Type: 8-K
Source: 0001493152-25-017436
Chunk: 2

Company: Beeline Holdings, Inc.
Filing Date: 2025-10-08
Form: 8-K
Item: Item 5.07
Chunk 2
---

                 5,726,389                         295,941                       16,844  

Proposal
3

  Votes For                     Votes Against                   Abstentions               
 ──────────────────────────────────────────────────────────────────────────────────────────
                 5,649,905                         182,387                       206,882  

As
there were sufficient votes to approve Proposals 1 through 3, Proposal 4 was moot.

Equity
Grants

As
a result of the stockholders’ approval of the 2025 Plan at the 2025 Annual Meeting, the following equity grants took effect on
October 2, 2025, as such grants were subject to stockholder approval in accordance with the rules of The Nasdaq Stock Market, LLC:

Nicholas
R. Liuzza, Jr., the Company’s Chief Executive Officer, director and principal stockholder, was granted 50,000 stock options exercisable
for 10 years at an exercise price of $1.01376 per share, vesting annually in equal amounts over two years from May 28, 2025, subject
to continued service on the applicable vesting date.

Christopher
R. Moe, the Company’s Chief Executive Officer was granted 235,000 stock options and Tiffany Milton, the Company’s Chief Accounting
Officer was granted 35,000 stock option, each exercisable for 10 years at an exercise price of $1.01376 per share, and vesting annually
in equal amounts over two years from May 28, 2025, subject to continued service on the applicable vesting date.

Joseph
Freedman, a director of the Company, was granted 10,000 shares of restricted stock vesting on October 2, 2025, 30,000 shares vesting
one-third annually over three years from May 28, 2025, 18,333 shares for prior work as of April 30, 2025, vesting on May 28, 2026; and
30,000 restricted stock units vesting on the earlier of one year from the grant date or delivery of a final report by the applicable
committee.

Joseph
Caltabiano, a director of the Company, was granted 10,000 shares of restricted stock vesting on October 2, 2025, 30,000 shares vesting
one-third annually over three years from May 28, 2025, 18,333 shares